Skip to main content

Welcome to our Annual Report and Form 20-F Information

David R Brennan, CEO

"I am confident that we are taking the right steps to better position AstraZeneca as we, and the industry, encounter increasingly challenging market conditions."

David R Brennan
Chief Executive Officer

Shareholder services

2007 Financial highlights

Sales

+7% to £29,559

Operating profit*

+% to £9,060

Dividend

+9% to $1.87

EPS*

+7% to $4.20

* excluding restructuring and synergy costs
> growth rates are at constant exchange rates

Downloads

You can also download the report in PDF format below.

You will need Adobe Reader to open PDF files. You can get it from Adobe.com

Further information

Visit AstraZeneca.com for: